Pathological and Nuclear Medicine Factors for Prognosis in Lung Carcinoma

Condition:   NSCLC Intervention:   Other: Clinical routine F18-FDG-PET/CT, molecular pathology and clinical outcome Sponsors:   Klinikum Bayreuth GmbH;   Beijing Cancer Hospital;   Sana Klinikum Hof Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials